{
 "drug": "Remifentanil Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "06/28/2022",
 "dayN": 1519,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Mylan Institutional, a Viatris Company",
  "Fresenius Kabi USA, LLC",
  "Hikma Pharmaceuticals USA, Inc."
 ],
 "reasons": [
  "Delay in shipping of the drug",
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "72078-035-02",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA020630"
    ],
    "brand_name": [
     "ULTIVA"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "72078-035",
     "72078-034",
     "72078-036"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729581",
     "1729584",
     "1729586",
     "1729710",
     "1729712"
    ],
    "spl_id": [
     "f41b6542-9305-43e7-bbbc-52c7ee2cb0dc"
    ],
    "spl_set_id": [
     "8b4c8696-e23e-4c51-a4d2-babab5bd945a"
    ],
    "package_ndc": [
     "72078-034-00",
     "72078-034-01",
     "72078-035-00",
     "72078-035-02",
     "72078-036-00",
     "72078-036-05"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Ultiva, Injection, 2 mg (NDC 72078-035-02)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "63323-724-05",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: September 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA206223"
    ],
    "brand_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-724",
     "63323-723",
     "63323-725"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729584",
     "1729710"
    ],
    "spl_id": [
     "2f27e51f-2b55-47ee-bd4a-001b71c60622"
    ],
    "spl_set_id": [
     "d2374b84-81c9-44f9-a4a9-1071281b2531"
    ],
    "package_ndc": [
     "63323-723-01",
     "63323-723-03",
     "63323-724-01",
     "63323-724-05",
     "63323-725-01",
     "63323-725-10"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "0143-9391-10",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA210594"
    ],
    "brand_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9391",
     "0143-9392",
     "0143-9393"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729584",
     "1729710"
    ],
    "spl_id": [
     "5c5e498b-d829-4f78-bcca-466631014767"
    ],
    "spl_set_id": [
     "9d289052-1eb6-4ba2-a3ca-d2e542a052ae"
    ],
    "package_ndc": [
     "0143-9391-01",
     "0143-9391-10",
     "0143-9392-01",
     "0143-9392-10",
     "0143-9393-01",
     "0143-9393-10"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "0143-9393-10",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots will be available.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA210594"
    ],
    "brand_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9393",
     "0143-9391",
     "0143-9392"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729584",
     "1729710"
    ],
    "spl_id": [
     "5c5e498b-d829-4f78-bcca-466631014767"
    ],
    "spl_set_id": [
     "9d289052-1eb6-4ba2-a3ca-d2e542a052ae"
    ],
    "package_ndc": [
     "0143-9391-01",
     "0143-9391-10",
     "0143-9392-01",
     "0143-9392-10",
     "0143-9393-01",
     "0143-9393-10"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "72078-034-01",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA020630"
    ],
    "brand_name": [
     "ULTIVA"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "72078-034",
     "72078-035",
     "72078-036"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729581",
     "1729584",
     "1729586",
     "1729710",
     "1729712"
    ],
    "spl_id": [
     "f41b6542-9305-43e7-bbbc-52c7ee2cb0dc"
    ],
    "spl_set_id": [
     "8b4c8696-e23e-4c51-a4d2-babab5bd945a"
    ],
    "package_ndc": [
     "72078-034-00",
     "72078-034-01",
     "72078-035-00",
     "72078-035-02",
     "72078-036-00",
     "72078-036-05"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "72078-036-05",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA020630"
    ],
    "brand_name": [
     "ULTIVA"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "72078-036",
     "72078-034",
     "72078-035"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729581",
     "1729584",
     "1729586",
     "1729710",
     "1729712"
    ],
    "spl_id": [
     "f41b6542-9305-43e7-bbbc-52c7ee2cb0dc"
    ],
    "spl_set_id": [
     "8b4c8696-e23e-4c51-a4d2-babab5bd945a"
    ],
    "package_ndc": [
     "72078-034-00",
     "72078-034-01",
     "72078-035-00",
     "72078-035-02",
     "72078-036-00",
     "72078-036-05"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Ultiva, Injection, 5 mg (NDC 72078-036-05)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "0143-9392-10",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA210594"
    ],
    "brand_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9392",
     "0143-9391",
     "0143-9393"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729584",
     "1729710"
    ],
    "spl_id": [
     "5c5e498b-d829-4f78-bcca-466631014767"
    ],
    "spl_set_id": [
     "9d289052-1eb6-4ba2-a3ca-d2e542a052ae"
    ],
    "package_ndc": [
     "0143-9391-01",
     "0143-9391-10",
     "0143-9392-01",
     "0143-9392-10",
     "0143-9393-01",
     "0143-9393-10"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "63323-725-10",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA206223"
    ],
    "brand_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-725",
     "63323-723",
     "63323-724"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729584",
     "1729710"
    ],
    "spl_id": [
     "2f27e51f-2b55-47ee-bd4a-001b71c60622"
    ],
    "spl_set_id": [
     "d2374b84-81c9-44f9-a4a9-1071281b2531"
    ],
    "package_ndc": [
     "63323-723-01",
     "63323-723-03",
     "63323-724-01",
     "63323-724-05",
     "63323-725-01",
     "63323-725-10"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/28/2022",
   "package_ndc": "63323-723-03",
   "generic_name": "Remifentanil Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA206223"
    ],
    "brand_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "generic_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-723",
     "63323-724",
     "63323-725"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "REMIFENTANIL HYDROCHLORIDE"
    ],
    "rxcui": [
     "1729578",
     "1729584",
     "1729710"
    ],
    "spl_id": [
     "406a07e3-a3f8-4fef-901e-021d00743c40",
     "2f27e51f-2b55-47ee-bd4a-001b71c60622"
    ],
    "spl_set_id": [
     "5b8025d2-3424-477b-9cff-3990a98c2a65",
     "d2374b84-81c9-44f9-a4a9-1071281b2531"
    ],
    "package_ndc": [
     "63323-723-04",
     "63323-723-06",
     "63323-723-01",
     "63323-723-03",
     "63323-724-01",
     "63323-724-05",
     "63323-725-01",
     "63323-725-10"
    ],
    "unii": [
     "5V444H5WIC"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  }
 ]
}